Innovations continue to surge at the interface of artificial intelligence and biotech, with notable developments in AI-enhanced virtual cell models, antibody discovery platforms, and laboratory automation. The Singapore-MIT SMART team developed the first automated tool for large-scale RNA modification analysis, advancing epitranscriptomics research. Meanwhile, a University of Illinois Urbana-Champaign group unveiled a high-throughput antibody testing platform accelerating discovery against viral antigens. Beckman Coulter and Hombrechtikon Systems Engineering introduced integrated photometer and fluorometer modules into automated liquid handling workflows, enhancing nucleic acid quantification efficiency and data integrity. These breakthroughs collectively represent growing momentum toward AI-driven acceleration of biomedical research and therapeutic development.